• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,243.34 -116.67
( -0.16%)
Global Indices
Nasdaq
51,098.17 -484.76
(-0.94%)
Dow Jones
7,440.28 -165.03
(-2.17%)
Hang Seng
66,711.59 -759.10
(-1.13%)
Nikkei 225
10,374.30 13.98
(0.13%)
Forex
USD-INR
95.73 0.01
(0.01%)
EUR-INR
111.21 0.07
(0.06%)
GBP-INR
128.58 -0.06
(-0.05%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

Dhyaani Tradeventtures Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
543516
INE0K5F01014
20.3442199
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
124.75
8.49
EPS(TTM)
Face Value()
Div & Yield %
0.04
10
0
 

Marksans Pharma consolidated net profit rises 8.26% in the December 2025 quarter
Feb 05,2026
Net profit of Marksans Pharma rose 8.26% to Rs 113.20 crore in the quarter ended December 2025 as against Rs 104.56 crore during the previous quarter ended December 2024. Sales rose 10.64% to Rs 754.43 crore in the quarter ended December 2025 as against Rs 681.85 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales754.43681.85 11
OPM %21.3120.35 -
PBDT174.95163.95 7
PBT150.62143.26 5
NP113.20104.56 8